A study to assess performance of a claims‐based fall risk prediction score developed by Homer et al. in the general population and optimize it in older adults taking oral anticoagulant (OAC) for non‐valvular Atrial fibrillation
Latest Information Update: 08 Dec 2020
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Thromboembolism
- Focus Pharmacodynamics
- 08 Dec 2020 New trial record